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constituting the immunosuppressive
microenvironment that causes poor
prognosis in EMPD, as well as in
breast cancer. In the accompanying
paper, we demonstrate a role for
RANKL-stimulated macrophages in
recruiting Tregs into the skin.
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TO THE EDITOR
Recent clinical trials have established a
central role for the T helper type 2 (Th2)
cytokines IL-4 and IL-13 in the pathol-
ogy of atopic dermatitis (AD) (Beck
et al., 2014). Although blockade of the
IL-4 and IL-13 receptors causes signiﬁ-
cant clearing of skin lesions, a direct
effect of Th2 cytokines on wound
healing processes has not yet been
demonstrated. Furthermore, AD patients
are frequently affected by infection with
the pathogen, Staphylococcus aureus
(Boguniewicz and Leung, 2011).
Elevated levels of staphylococcal
products are frequently found on the
skin of affected patients (Travers et al.,
2010), and these products may affect
the wound healing process as well.
A primary event in skin healing is
induction of matrix metalloproteinases
(MMPs) (Inoue et al., 1995). MMPs-1,
-9, and -10 are expressed at the leading
edge of the wound (Inoue et al., 1995;
Rechardt et al., 2000; Turchi et al.,
2003) and are required for keratino-
cyte migration into the damaged area
(Pilcher et al., 1997; Agren, 1999). Inhi-
bition of MMP function effectively
blocks keratinocyte migration and
wound healing (Mirastschijski et al.,
2002b). However, overexpression of
MMPs has been reported in skin dis-
eases and can inhibit wound closure as
well (Saarialho-Kere et al., 1994;
Mirastschijski et al., 2002a). In this
study, we determined the effects of
staphylococcal products and AD-
associated Th2 cytokines on MMP
expression and on keratinocyte
migration.
We ﬁrst examined the effect of
bacterial products on MMP levels.Accepted article preview online 7 May 2015; published online 28 May 2015
Abbreviations: AD, atopic dermatitis; LTA, lipoteichoic acid; MMP, matrix metalloproteinase;
siRNA, small interfering RNA; STAT6, signal transducer and activator of transcription 6;
Th2, T helper type 2; TIMP, tissue inhibitor of metalloproteinase; TNF-α, tumor necrosis factor-α
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Real-time PCR and ELISAs were used to
quantify mRNA and protein expression
of MMP-1, -9, and -10. We found that
these MMPs were signiﬁcantly induced
by exposure to staphylococcal lipotei-
choic acid (LTA) (Figure 1a and
Supplementary Figure S1 online). Pepti-
doglycan also modestly induced these
MMPs. In contrast, neither E. coli–derived
lipopolysaccharide nor the staphylococ-
cal toxins S. aureus enterotoxin B and
Toxic Shock Syndrome Toxin were able
to induce expression of MMPs
(Figure 1a). We also found that LTA-
induced events are dependent upon
expression of the Toll-like receptor signal-
ing adaptor molecule, MyD88, as a
MyD88 peptide inhibitor completely
blocked gene expression of MMP-1, -9,
and -10 (Supplementary Figure S2
online). We next determined the effect
of Th2 cytokines on MMP production.
We found that basal level expression of
MMP-9 was inhibited by Th2 cytokines
(Figure 1b and c). LTA-induced expres-
sion of MMP-1, -9, and -10 was also
signiﬁcantly inhibited by Th2 cytokines.
(Figure 1b and c). These results demon-
strate that Th2 cytokines interfere with
both basal and LTA-induced MMP
expression. For comparison, tumor necro-
sis factor-α (TNF-α) does not interfere with
MMP expression (Supplementary Figure
S3 online), as previously described (Han
et al., 2001). Expression of tissue inhibitor
of metalloproteinase (TIMPs) was also
examined. In contrast to MMPs, TIMP
levels were not substantially altered by
LTA or Th2 cytokines (Supplementary
Figure S4 online).
We next focused on determining the
molecular events induced by Th2 cyto-
kines that inﬂuence MMP gene expres-
sion. Signal transducer and activator of
transcription 6 (STAT6) is a transcrip-
tion factor activated by ligation of the
IL-4 and IL-13 receptors (Albanesi
et al., 2007). We therefore used
small interfering RNA (siRNA) directed
against STAT6 to determine whether
Th2 cytokines signal through STAT6 to
modulate MMP levels. Figure 2a
demonstrates that basal MMP-9 expres-
sion is inhibited by Th2 cytokines in
control but not in STAT6 siRNA–treated
cells. Furthermore, the Th2-mediated
inhibition of LTA-induced MMP expres-
sion was no longer observed in STAT6
siRNA–treated keratinocytes (Figure 2a).
The increased expression of MMPs
in STAT6 knockdown cells was signi-
ﬁcant. Therefore, we conclude that the
inhibition of MMP expression by Th2
cytokines is dependent upon STAT6.
As MMPs coordinate epithelial wound
healing by enabling cell detachment and
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Figure 1. Staphylococcus aureus LTA–induced expression of matrix metalloproteinases (MMPs) is inhibited by T helper type 2 (Th2) cytokines. (a) Normal
human epidermal keratinocytes were cultured in medium or medium additionally containing 5 μgml−1 of LTA, 5 μgml−1 lipopolysaccharide, (LPS), 5 μgml−1
peptidoglycan (PG), 5 μgml−1 S. aureus enterotoxin B (SEB), or 5 μgml−1 Toxic Shock Syndrome Toxin (TSST) for 24 hours. Real-time PCR was used to quantify
mRNA, and the levels were normalized to beta actin. Fold change values were calculated relative to media control for MMP-1, -9, and -10. (b) Keratinocytes were
pre-treated with medium or IL-4/IL-13 for 24 hours. Following pre-treatment, cells were then cultured in the presence or absence of LTA for an additional
24 hours. Gene expression was analyzed by real-time PCR, for MMP-1, MMP-9, and MMP-10, and normalized to beta actin. Fold change in MMP expression
was measured relative to medium control. (c) Protein levels were measured by ELISA for MMP-1, MMP-9, and MMP-10. Data are expressed as mean± SEM,
n= 3. *Po0.05; **Po0.01; ***Po0.001 (as compared with the cells grown in medium alone).
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migration on collagen (Pilcher et al.,
1997), we further investigated whether
Th2 cytokines inhibited ‘‘wound’’ closure
in a monolayer of human keratinocytes
grown on a collagen matrix. Using an
in vitro wound scratch assay, we ﬁnd
that cells treated with media alone but
disrupted by the scratch migrated into the
depleted area (Figure 2b). In contrast, pre-
treatment with Th2 cytokines inhibited
the rate of keratinocyte migration com-
pared with control keratinocytes (Figure
2b and c). Possibly because of the
endogenous activation of MMPs at the
leading edge (Pilcher et al., 1997; Turchi
et al., 2003), we did not observe an
additive effect of LTA on wound closure
in a scratch assay (Figure 2b and c).
However, we do observe that Th2
cytokines have a dominant inhibitory
effect, blocking migration in all cases.
For comparison, the cytokine TNF-α did
not inhibit the closure of keratinocyte
monolayers (Supplementary Figure S3
online), as previously described (Eyerich
et al., 2009). Consistent with the observed
effects on MMP expression, the inhibition
of migration mediated by Th2 cytokines
was ablated in Stat6 siRNA–treated cells
(Figure 2c). Therefore, Th2 inhibition of
migration related to wound closure is also
dependent on STAT6.
A critical role for Th2 cytokines in AD
skin disease is emerging. Here we
directly demonstrate that Th2 cytokines
inhibit MMP expression and keratino-
cyte migration, both essential compo-
nents of the wound healing process.
There is, however, a paradoxical effect
of MMPs in wound healing. Although
MMPs are required for normal migra-
tion leading to wound closure, over-
expression is a key feature of chronic
wounds and skin disease. It therefore
remains possible that overexpression of
MMPs induced by LTA may contribute
to skin disease as well. Recent studies
have evaluated MMP expression in AD
skin (Esaki et al., 2015). Using micro-
dissection techniques, AD skin was
sectioned into dermal and epidermal
components. MMP-1, a gene induced
by staphylococcal LTA, was identiﬁed
as the most prominently upregulated
gene in the dermis. As AD lesions are
frequently infected with S. aureus, it
seems possible that LTA-induced over-
expression of MMPs may be a contri-
buting factor in disease. In contrast,
increases in MMP-1, -9, or -10 levels in
the epidermis of lesional AD skin were
not reported (in a list of the top 25 most
upregulated genes). However, this may
be a consequence of the inhibitory
effects of Th2 cytokines. We propose
that Th2 cytokines, as well as
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Figure 2. Th2 cytokine inhibition of matrix metalloproteinase (MMP) expression and keratinocyte migration requires signal transducer and activator of
transcription 6 (STAT6). Primary keratinocytes were transfected with control (non-targeting) or STAT6 siRNA. Transfected cells were then treated with media
alone or IL-4/13, LTA, or a combination of LTA and IL-4/13. (a) Gene expression was analyzed by real-time PCR, for MMP-1, MMP-9, and MMP-10, and
normalized to beta actin. Fold change in MMP expression was measured relative to medium control. (b) Keratinocytes were cultured with medium alone or with
IL-4/IL-13 for 24 hours. Following pre-treatment, cells were then cultured in the absence or presence of LTA for an additional 24 hours. The cells were then
scratched with a pipette tip. The deﬁned area of the wound was photographed under phase-contrast microscopy at time 0 and at 24 hours. Representative ﬁelds
show the wound gap at the indicated times. Scale bar is 100 μm. (c) Primary keratinocytes were transfected with control (non-targeting) or STAT6 siRNA.
Transfected cells were then treated with media alone or IL-4/13, LTA, or a combination of LTA and IL-4/13 as described above. Cells were scratched and the
closure of the wounded area at 24 hours was quantitated. Data are expressed as mean± SEM, n=3. ***Po0.001 (as compared with cells grown in medium
alone). siRNA, small interfering RNA; Th2, T helper type 2.
AM Brauweiler et al.
Th2 Cytokines Suppress Keratinocyte Migration
2552 Journal of Investigative Dermatology (2015), Volume 135
staphylococcal LTA, may contribute to
delayed wound healing and pathology
associated with AD by deregulating
MMP production and altering cell
migration.
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